Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

PharmaCCX Completes SOC 2 Type 1 Report with Laika

PharmaCCX, the leading provider of innovative access agreement infrastructure software, announced today that it has completed its SOC 2 Type 1 examination. Achieving SOC 2 compliance is a significant milestone for PharmaCCX, as it demonstrates the company’s commitment to the industry’s highest standards for managing customer data.

By achieving SOC 2 compliance, PharmaCCX clients (payers and pharmaceutical companies) in the healthcare space will benefit from added layers of trust including security, availability, processing, integrity, confidentiality and privacy.

Recommended AI News: Nephio Sees Rapid Growth as More Organizations Commit to Simplify Cloud Native Automation of Telecom Network Functions

SOC 2 is a rigorous compliance standard developed by the American Institute of Certified Public Accountants (AICPA) that is designed to specify how organizations should manage customer data. Through the process an organization’s internal controls for privacy and information security are examined, assessing compliance at a specific point in time.

To earn this report, PharmaCCX worked closely with compliance-as-a-service platform Laika, which helps companies manage information security and privacy compliance, obtain security certifications and build trust with customers.

Related Posts
1 of 38,393

Recommended AI News: Vodafone Partners with Oracle to Accelerate Technology Modernization on Oracle Cloud Infrastructure

“Our clients’ data is paramount, and that commitment to security is part of PharmaCCX’s DNA,” said Armen Solakhyan, Chief Technology Officer at PharmaCCX. “SOC 2 report is a milestone that validates the intention we have put into designing our platform and procedures.  Our client’s need to trust that when they share data with us it will be handled in a safe and secure manner.”

“SOC 2 compliance is table stakes for vendors that want to build credibility with clients,” said Eva Pittas, founder and COO, Laika. “PharmaCCX is creating an overall culture of compliance, exemplified by their commitment to SOC 2.”

PharmaCCX has already begun work with Laika on its SOC 2 Type 2 examination and ISO 27001 certifications, both of which PharmaCCX is expected to complete in the next year.\

Recommended AI News: CloudNC Raises $45 Million to Deliver Autonomous Manufacturing

[To share your insights with us, please write to]

Comments are closed.